Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever.
Jun
Huang Xiao
HX
Zhixiang
Shen
S
Chun
Wang
W
Reksodiputro
A Harryanto
AH
Ranuhardy
Dody
D
Tamura
Kazuo
K
Matsumoto
Tetsuro
T
Lee
Dong-Gun
DG
Purushotaman
S Visalachy
SV
Lim
Victor
V
Ahmed
Altaf
A
Hussain
Yasser
Y
Chua
Manolito
M
Ong
Adrian
A
Liu
Cheng-Yi
CY
Hsueh
Po-Ren
PR
Lin
Shaeng-Fung
SF
Liu
Yung-Ching
YC
Suwangool
Panpit
P
Jootar
Saengsuree
S
Picazo
Juan J
JJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D004359:Drug Therapy, Combination; D005335:Fever of Unknown Origin / Q000150:complications* / Q000188:drug therapy*; D017408:Guidelines as Topic / Q000592:standards*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy*; D012307:Risk Factors; D016896:Treatment Outcome; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000627:therapeutic use; D047090:beta-Lactams / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D065093:beta-Lactamase Inhibitors; D047090:beta-Lactams; D001618:beta-Lactamases